Clinical characteristics of study patients
. | HIV-infected patients . | . | . | . | |
|---|---|---|---|---|---|
. | Naive . | Treated . | Norovirus . | Control . | |
| No. | 13 | 13 | 6 | 12 | |
| Age, y (range) | 50 (25-75) | 53 (30-75) | 72(62-85) | 51(27-78) | |
| Sex, no. men/no. women | 11/2 | 11/2 | 4/2 | 11/1 | |
| Median CD4 count, cells per μL blood (range) | 330 (43-627) | 401 (110-927) | ND | ND | |
| Median HIV load, log10 copies per mL (range) | 4.98 (3.67-6.18) | < LOD | NA | NA | |
| CDC stage, no. patients | |||||
| A | 2 | 3 | NA | NA | |
| B | 6 | 6 | NA | NA | |
| C | 5 | 4 | NA | NA | |
. | HIV-infected patients . | . | . | . | |
|---|---|---|---|---|---|
. | Naive . | Treated . | Norovirus . | Control . | |
| No. | 13 | 13 | 6 | 12 | |
| Age, y (range) | 50 (25-75) | 53 (30-75) | 72(62-85) | 51(27-78) | |
| Sex, no. men/no. women | 11/2 | 11/2 | 4/2 | 11/1 | |
| Median CD4 count, cells per μL blood (range) | 330 (43-627) | 401 (110-927) | ND | ND | |
| Median HIV load, log10 copies per mL (range) | 4.98 (3.67-6.18) | < LOD | NA | NA | |
| CDC stage, no. patients | |||||
| A | 2 | 3 | NA | NA | |
| B | 6 | 6 | NA | NA | |
| C | 5 | 4 | NA | NA | |
CDC stage indicates active disease as defined by Centers for Disease Control and Prevention classification; ND, not determined; < LOD, below limit of detection (< 50 copies per milliliter); NA, not applicable.